|
Manito Lorite N, Rubio-Rodriguez D, Gonzalez Costello J, Diez Lopez C, Enjuanes Grau C, Segovia-Cubero J, Delgado Jimenez JF, Campo Sien C, Rubio-Terres C, Comin-Colet J; LION-HEART study researchers; Additional researchers in the LION-HEART Group. Economic analysis of intermittent intravenous outpatient treatment with levosimendan in advanced heart failure in Spain. Rev Esp Cardiol (Engl Ed). 2020 May;73(5):361-367. doi: 10.1016/j.rec.2019.06.020. Epub 2019 Dec 30. English, Spanish. PubMed PMID: 31899185.
AÑO: 2020; IF: 4.753
|
31899185
|
Pascual-Figal D, Wachter R, Senni M, Bao W, Noe A, Schwende H, Butylin D, Prescott MF; TRANSITION Investigators. NT-proBNP Response to Sacubitril/Valsartan in Hospitalized Heart Failure Patients With Reduced Ejection Fraction: TRANSITION Study. JACC Heart Fail. 2020 Oct;8(10):822-833. doi: 10.1016/j.jchf.2020.05.012. Epub 2020 Aug 12. PubMed PMID: 32800508.
AÑO: 2020; IF: 12.035
|
|
Escobar C, Barrios V, Cortes CO, Sales JC, Pascual Figal DA, Marimon XG. Recommendations to improve the management and the prognosis of patients with heart failure. Future Cardiol. 2020 Jan;16(1):1-4. doi: 10.2217/fca-2019-0042. Epub 2019 Nov 25. No abstract available. PubMed PMID: 31762325.
AÑO: 2020
|
|
Packer M, Anker SD, Butler J, Filippatos G, Pocock SJ, Carson P, Januzzi J, Verma S, Tsutsui H, Brueckmann M, Jamal W, Kimura K, Schnee J, Zeller C, Cotton D, Bocchi E, Bohm M, Choi DJ, Chopra V, Chuquiure E, Giannetti N, Janssens S, Zhang J, Gonzalez Juanatey JR, Kaul S, Brunner-La Rocca HP, Merkely B, Nicholls SJ, Perrone S, Pina I, Ponikowski P, Sattar N, Senni M, Seronde MF, Spinar J, Squire I, Taddei S, Wanner C, Zannad F; EMPEROR-Reduced Trial Investigators. Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure. N Engl J Med. 2020 Oct 8;383(15):1413-1424. doi: 10.1056/NEJMoa2022190. Epub 2020 Aug 28. PubMed PMID: 32865377.
AÑO: 2020; IF: 91.245
|
|
Senni M, Wachter R, Witte KK, Straburzynska-Migaj E, Belohlavek J, Fonseca C, Mueller C, Lonn E, Chakrabarti A, Bao W, Noe A, Schwende H, Butylin D, Pascual-Figal D; TRANSITION Investigators. Initiation of sacubitril/valsartan shortly after hospitalisation for acutely decompensated heart failure in patients with newly diagnosed (de novo) heart failure: a subgroup analysis of the TRANSITION study. Eur J Heart Fail. 2020 Feb;22(2):303-312. doi: 10.1002/ejhf.1670. Epub 2019 Dec 9. PubMed PMID: 31820537.
AÑO: 2020; IF: 15.534
|